AJ, S., H, X., S, G., I, N., P, R., D, H., . . . JJ, C. (2017). Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: Subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study. Dove Medical Press.
Style de citation Chicago (17e éd.)AJ, Savitz, et al. Efficacy and Safety of Paliperidone Palmitate Three-monthly Formulation in East Asian Patients with Schizophrenia: Subgroup Analysis of a Global, Randomized, Double-blind, Phase III, Noninferiority Study. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)AJ, Savitz, et al. Efficacy and Safety of Paliperidone Palmitate Three-monthly Formulation in East Asian Patients with Schizophrenia: Subgroup Analysis of a Global, Randomized, Double-blind, Phase III, Noninferiority Study. Dove Medical Press, 2017.